Increase in Medicare Part B Spending on Genetic Testing Exposes Regulatory Challenges
The OIG report reveals a 5% rise in Medicare Part B spending on lab tests, focusing on genetic testing compliance challenges and regulatory scrutiny in healthcare.
The OIG report reveals a 5% rise in Medicare Part B spending on lab tests, focusing on genetic testing compliance challenges and regulatory scrutiny in healthcare.